High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.

Lala M Dunbar; Richard G Wunderink; Michael P Habib; Leon G Smith; Alan M Tennenberg; Mohammed M Khashab; Barbara A Wiesinger; Jim X Xiang; Neringa Zadeikis; James B Kahn

doi:10.1086/377539

High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.

Identifier:nobleid.org/w1/20260515/C8BCCD63

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C8BCCD63.svg?ark=w1%2F20260515%2FC8BCCD63)](https://nobleid.org/work/w1/20260515/C8BCCD63)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.

Identifier:nobleid.org/w1/20260515/C8BCCD63

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C8BCCD63.svg?ark=w1%2F20260515%2FC8BCCD63)](https://nobleid.org/work/w1/20260515/C8BCCD63)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work